![Marino Garcia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marino Garcia
Verkställande Direktör på
DIANTHUS THERAPEUTICS, INC.
Förmögenhet: 6 M $ per 2026-09-30
Profil
Mr. Marino Garcia is a President, Chief Executive Officer & Director at Dianthus Therapeutics, Inc. and a President, Chief Executive Officer & Director at Dianthus Therapeutics OpCo, Inc. He is on the Board of Directors at AgomAb Therapeutics NV, Dianthus Therapeutics, Inc. and Dianthus Therapeutics OpCo, Inc. Mr. Garcia was previously employed as a Senior VP-Corporate & Business Development by Zealand Pharma A/S, a Chief Strategy Officer & Executive Vice President by Synergy Pharmaceuticals, Inc., a Vice President-Business Development by Aptalis Pharma Canada,Inc., and a Vice President-US Commercial Operations by Aspreva Pharmaceuticals Corp.
He received his undergraduate degree from Concordia University and an MBA from Richard Ivey School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-07 | 65 292 ( 0,2 % ) | 6 M $ | 2026-09-30 |
Aktiva positioner av Marino Garcia
| Företag | Position | Start |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Verkställande Direktör | 2023-09-11 |
| AGOMAB THERAPEUTICS NV | Direktör/Styrelseledamot | 2026-09-11 |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Verkställande Direktör | 2021-11-01 |
Tidigare kända positioner av Marino Garcia
| Företag | Position | Slut |
|---|---|---|
| ZEALAND PHARMA A/S | Företagsledare/Principal | 2021-10-01 |
| SYNERGY PHARMACEUTICALS INC | Företagsledare/Principal | 2018-09-30 |
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Företagsledare/Principal | 2014-03-13 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | 2010-01-01 |
Marino Garcias utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
